Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 331.50
+1.50 (0.45%)
Jul 2, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €2.76 billion as of July 2, 2026. Its market cap has increased by 1.58% in one year.
Market Cap
2.76B
Enterprise Value
2.93B
Revenue
1.46B
Ranking
n/a
PE Ratio
18.33
Stock Price
€331.50
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 2.76B, an increase of 1,171.00%. That is a compound annual growth rate of 8.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.76B | -7.69% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 90.62B |
| EssilorLuxottica Société anonyme | 75.17B |
| Sartorius Stedim Biotech | 17.35B |
| Ipsen | 13.55B |
| bioMérieux | 8.24B |
| ABIVAX Société Anonyme | 6.64B |
| emeis Société anonyme | 2.23B |
| Nanobiotix | 1.58B |